Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by William Seibel
IODVA1, a Guanidinobenzimidazole Derivative, Targets Rac Activity and Ras-Driven Cancer Models
PLoS ONE
Multidisciplinary
Bisbenzimidazoles: Anticancer Vacuolar (H+)-ATPase Inhibitors
Related publications
G Protein Subunit-Dependent Rac-Guanine Nucleotide Exchange Activity of Ras-Grf1/CDC25Mm
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Stressing Rac, Ras, and Downstream Heat Shock Protein 70
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
Antitumor Activity in RAS-Driven Tumors by Blocking AKT and MEK
Clinical Cancer Research
Cancer Research
Oncology
Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors
Cancer Cell
Cancer Research
Oncology
Cell Biology
Identification of Cancer Initiating Cells in K-Ras Driven Lung Adenocarcinoma
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Targeting Ras-Driven Cancer Cell Survival and Invasion Through Selective Inhibition of DOCK1
Cell Reports
Biochemistry
Genetics
Molecular Biology
KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer
Frontiers in Oncology
Cancer Research
Oncology
CXL146, a Novel 4h-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug Resistant Cancer Cells
Molecular Pharmacology
Molecular Medicine
Pharmacology
Molecular Targets in Urothelial Cancer: Detection, Treatment, and Animal Models of Bladder Cancer
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science